ANDERSON ELIZABETH M 4
4 · Revolution Medicines, Inc. · Filed Jun 30, 2025
Insider Transaction Report
Form 4
ANDERSON ELIZABETH M
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-26+11,574→ 11,574 totalExercise: $37.48Exp: 2035-06-26→ Common Stock (11,574 underlying) - Award
Common Stock
2025-06-26+3,142→ 23,215 total
Holdings
- 26,990(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by David W. Anderson 1996 Irrevocable Trust.
- [F2]Includes 3,142 Restricted Stock Units.
- [F3]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.